Notably, ERBB1 ligands AREG and EGF have been shown to stimulate the proliferation of multiple myeloma (MM) cells [21,22], and inhibiting ERBB1 caused cytotoxicity to MM cells [23,24]. The gene discussed is EGFR; the disease is plasma cell myeloma.